Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis.
Saved in:
| Title: | Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis. |
|---|---|
| Authors: | Lee WC; Health Economics & Outcomes Research, IMS Consulting Group, Alexandria, VA 22314, USA. wclee@imscg.com, Samyshkin Y, Langer J, Palmer JL |
| Source: | Journal of medical economics [J Med Econ] 2012; Vol. 15 Suppl 2, pp. 28-37. Date of Electronic Publication: 2012 Aug 13. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
